Randomized Controlled Clinical Trial Of Ajmoda Dhumapana With And Without Using Breathing Mask In Traffic Policemen of PCMC Using Peak Expiratory Flow Rate (PEFR)
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 64
- 试验地点
- 1
- 主要终点
- Improvement in PEFR and air pollution related respiratory ailments after use of ajmoda dhumapana.
研究概览
简要总结
1.In this era of air pollution even healthy people experience health impacts including respiratory irritation or breathing difficulties. The risk do adverse effects depends on health status, the pollutant type, and concentration and length of exposure to polluted air.
-
It contains essential oil thymol which has antispasmodic activity on smooth muscles of trachea by acting on beta receptores of bronchus .It also has broncholytic effect and increases mucociliary action .
-
PEFR is a reliable indicator of lung function . PEFR depends on the force of contraction of expiratory muscles, elastic recoil of lungs and resistance of bronchial tree. Reduction in PEFR values may indicate the risk of obstructive airway disease in the occupational heath workers like Traffic Policemen who work in bus traffic signal areas for years together and are exposed to air pollutants everyday.
-
Therefore this study will assess effect of ajmoda dhumapana on air pollution related respiratory ailments using peak expiratory flow rate which is reliable indicator of lung function.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 55.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Traffic policemen having air pollution related respiratory ailments.( acute or chronic bronchitis,atopic asthma,sinusitis,rhinitis,bronchospasm)
- •Non smokers 3.Age group 20-55 years.
- •4.PEFR -Yellow and green zone.
- •5.no major systemic illness.
排除标准
- •Age group above 55 years.
- •3.Respiratory failure, chronic obstructive pulmonary disease,lung cancer,interstitial lung disease.
- •4.Dhumapana anarha ( raktapitta,murcha,jagaran paschat etc) 5.PEFR-Red zone.
结局指标
主要结局
Improvement in PEFR and air pollution related respiratory ailments after use of ajmoda dhumapana.
时间窗: Improvement in PEFR will be assessed at 15th day of trial and at end of trial (30th day of trial).
次要结局
- Improvement in PEFR and air pollution related respiratory ailments after use of ajmoda dhumapana.(30 days)
